Literature DB >> 27098219

Hemodynamic Performance and Thrombogenic Properties of a Superhydrophobic Bileaflet Mechanical Heart Valve.

David L Bark1,2, Hamed Vahabi1, Hieu Bui2, Sanli Movafaghi1, Brandon Moore1, Arun K Kota1,2, Ketul Popat1,2, Lakshmi P Dasi3,4,5.   

Abstract

In this study, we explore how blood-material interactions and hemodynamics are impacted by rendering a clinical quality 25 mm St. Jude Medical Bileaflet mechanical heart valve (BMHV) superhydrophobic (SH) with the aim of reducing thrombo-embolic complications associated with BMHVs. Basic cell adhesion is evaluated to assess blood-material interactions, while hemodynamic performance is analyzed with and without the SH coating. Results show that a SH coating with a receding contact angle (CA) of 160° strikingly eliminates platelet and leukocyte adhesion to the surface. Alternatively, many platelets attach to and activate on pyrolytic carbon (receding CA = 47), the base material for BMHVs. We further show that the performance index increases by 2.5% for coated valve relative to an uncoated valve, with a maximum possible improved performance of 5%. Both valves exhibit instantaneous shear stress below 10 N/m2 and Reynolds Shear Stress below 100 N/m2. Therefore, a SH BMHV has the potential to relax the requirement for antiplatelet and anticoagulant drug regimens typically required for patients receiving MHVs by minimizing blood-material interactions, while having a minimal impact on hemodynamics. We show for the first time that SH-coated surfaces may be a promising direction to minimize thrombotic complications in complex devices such as heart valves.

Entities:  

Keywords:  Bileaflet mechanical heart valve; Blood; Shear stress; Superhydrophobic; Thrombosis; Turbulence

Mesh:

Year:  2016        PMID: 27098219      PMCID: PMC5073049          DOI: 10.1007/s10439-016-1618-2

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  60 in total

1.  Hemocompatibility of titania nanotube arrays.

Authors:  Barbara S Smith; Sorachon Yoriya; Laura Grissom; Craig A Grimes; Ketul C Popat
Journal:  J Biomed Mater Res A       Date:  2010-11       Impact factor: 4.396

2.  Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?

Authors:  Gemma Conn; Asmeret G Kidane; Geoffrey Punshon; Ruben Y Kannan; George Hamilton; Alexander M Seifalian
Journal:  Expert Rev Med Devices       Date:  2006-03       Impact factor: 3.166

Review 3.  Medical device-induced thrombosis: what causes it and how can we prevent it?

Authors:  I H Jaffer; J C Fredenburgh; J Hirsh; J I Weitz
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

4.  Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old.

Authors:  Tsuyoshi Kaneko; Sary Aranki; Quratulain Javed; Siobhan McGurk; Prem Shekar; Michael Davidson; Lawrence Cohn
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-27       Impact factor: 5.209

5.  Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators.

Authors:  M C Vrolix; V M Legrand; J H Reiber; G Grollier; M J Schalij; P Brunel; L Martinez-Elbal; M Gomez-Recio; F W Bär; M E Bertrand; A Colombo; J Brachman
Journal:  Am J Cardiol       Date:  2000-08-15       Impact factor: 2.778

6.  Cardiac valve replacement in children: comparison of tissue with mechanical prostheses.

Authors:  R M Sade; J F Ballenger; A R Hohn; J E Arrants; D A Riopel; A B Taylor
Journal:  J Thorac Cardiovasc Surg       Date:  1979-07       Impact factor: 5.209

7.  Flow and thrombosis at orifices simulating mechanical heart valve leakage regions.

Authors:  Anna M Fallon; Nisha Shah; Ulla M Marzec; James N Warnock; Ajit P Yoganathan; Stephen R Hanson
Journal:  J Biomech Eng       Date:  2006-02       Impact factor: 2.097

Review 8.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

9.  Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.

Authors:  Paolo Stassano; Luigi Di Tommaso; Mario Monaco; Francesco Iorio; Paolo Pepino; Nicola Spampinato; Carlo Vosa
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

10.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L Nolasco; J D Hellums
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

View more
  5 in total

Review 1.  Review of numerical methods for simulation of mechanical heart valves and the potential for blood clotting.

Authors:  Mohamad Shukri Zakaria; Farzad Ismail; Masaaki Tamagawa; Ahmad Fazli Abdul Aziz; Surjatin Wiriadidjaja; Adi Azrif Basri; Kamarul Arifin Ahmad
Journal:  Med Biol Eng Comput       Date:  2017-07-26       Impact factor: 2.602

2.  Hemocompatibility of Super-Repellent surfaces: Current and Future.

Authors:  Sanli Movafaghi; Wei Wang; David L Bark; Lakshmi P Dasi; Ketul C Popat; Arun K Kota
Journal:  Mater Horiz       Date:  2019-05-15       Impact factor: 13.266

3.  Clinical mid-term outcomes of the Chinese-made CL-V bileaflet mechanical heart valve in Chinese patients.

Authors:  Liang Qi; Shidong Liu; Yan Qiang; Honglin Zhao; Ruisheng Liu; Dianwei Cheng; Bing Song; Quanlin Guan
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

4.  Adverse Hemodynamic Conditions Associated with Mechanical Heart Valve Leaflet Immobility.

Authors:  Fardin Khalili; Peshala P T Gamage; Richard H Sandler; Hansen A Mansy
Journal:  Bioengineering (Basel)       Date:  2018-09-16

Review 5.  Potential of Superhydrophobic Surface for Blood-Contacting Medical Devices.

Authors:  Xun Hui Wu; Yun Khoon Liew; Chun-Wai Mai; Yoon Yee Then
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.